8.76
Finanzdaten der Ocular Therapeutix Inc-Aktie (OCUL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
8.90%
13.25
|
14.54 | 13.46 | 10.70 | 15.43 |
| Cost Of Revenue |
10.15%
1.594
|
1.774 | 1.944 | 1.262 | 1.561 |
| Gross Profit |
8.72%
11.66
|
12.77 | 11.52 | 9.436 | 13.86 |
|
|
0.06%
81.42
|
81.47 | 79.16 | 73.35 | 59.86 |
| Benefits Costs and Expenses |
6.41%
77.90
|
83.24 | 81.10 | 74.75 | 61.42 |
| Costs And Expenses |
0.28%
83.01
|
83.24 | 81.10 | 74.61 | 61.42 |
| Operating Income/Loss |
1.55%
-69.76
|
-68.70 | -67.64 | -63.92 | -46.00 |
| Nonoperating Income/Loss |
809.17%
5.106
|
-0.72 | -0.173 | -0.136 | 9.505 |
| Income/Loss From Continuing Operations Before Tax |
5.89%
-64.65
|
-68.70 | -67.81 | -64.05 | -46.00 |
| Income/Loss From Continuing Operations After Tax |
6.86%
-64.65
|
-69.42 | -67.81 | -64.05 | -36.49 |
|
|
6.86%
-64.65
|
-69.42 | -67.81 | -64.05 | -36.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
93.54%
11.88
|
183.92 | 172.59 | 169.40 | 166.99 |
| Diluted Average Shares |
93.54%
11.88
|
183.92 | 172.59 | 169.40 | 166.99 |
| Basic Earnings Per Share |
28.95%
-0.27
|
-0.38 | -0.39 | -0.38 | -0.22 |
| Diluted Earnings Per Share |
28.95%
-0.27
|
-0.38 | -0.39 | -0.38 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):